Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Atherosclerosis|May 22, 2015
Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of CardiologyGuy De Backer, Joost Besseling, John Chapman, et al.
European Cardiology|January 12, 2026
Expert Opinion on Targeted Lipid Control for Very-high-risk Indian Patients: Bridging the Gap in Real-world PracticeKausik Ray, Upendra Kaul, Srinivasa Rao, et al.
American Heart Journal|February 5, 2025
Rationale, design and prerandomization data for a cluster randomized trial to assess the effect of a digitally enabled quality improvement intervention on LDL-C control in established atherosclerotic cardiovascular disease patients: The SAPPHIRE-LDL trialM Julia Machline-Carrion, Alysson Nathan Girotto, Priscila Raupp, et al.
Cureus|July 6, 2026
Dyslipidemia Management in the Middle East: Recommendations for Overcoming Challenges and Enhancing Outcomes With PitavastatinAhmad J AlSarraf, Zuhier Awan, Osama Baghal, et al.
Thrombosis and Haemostasis|December 4, 2015
The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trialsAmirhossein Sahebkar, Corina Serban, Sorin Ursoniu, et al.
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study]Antonina Giammanco, Rosanna Gambacurta, Ioanna Gouni-Berthold, et al.
Cardiovascular Diagnosis and Therapy|February 7, 2017
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT studyJordan Andrews, Alex Janssan, Tracy Nguyen, et al.
Nature Communications|February 18, 2011
Gipc3 mutations associated with audiogenic seizures and sensorineural hearing loss in mouse and humanNikoletta Charizopoulou, Andrea Lelli, Margit Schraders, et al.
European Heart Journal|October 23, 2010
Lipoprotein(a) as a cardiovascular risk factor: current statusBørge G Nordestgaard, M John Chapman, Kausik Ray, et al.
Clinical Cardiology|August 21, 2018
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trialStephen J Nicholls, A Michael Lincoff, Dianna Bash, et al.
Pageof 5